V Foundation Adult Translational Cancer Research Award 2025
Apply to Internal Competition // Limit: 2 (1 Translational nominee, 1 All-Star Translational nominee) // Tickets Available: 2
The University of Arizona Cancer Center (UACC) can nominate up to two proposals: one Translational nominee and one All-Star Translational nominee (if eligible) for the V Foundation Adult Translational Cancer Research Award 2025.
For more information please contact: UACC-PreAward.
Purpose of Award:
The UACC is seeking nominations for the Translational Adult Cancer Research Grant which advances basic laboratory discoveries towards clinical use, ultimately improving human health and is restricted to adult cancer research.
This Translational grant is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. Research on ANY adult cancer type can be funded. Applicants may propose cancer research that moves a novel strategy from the laboratory into a human clinical trial or uses specimens from a clinical trial to test hypotheses, develop biomarkers, or mechanisms. The research must apply in a direct way to human beings within 3 years from the end of the grant. If biomarker research is undertaken, a validation set or independent clinical trial is essential. A plan for biomarker validation, if applicable, must be included in any proposal. The endpoint of the project should be the planning or initiation of a new clinical trial or conducting an investigator-initiated trial with laboratory correlates that test hypotheses. Research areas not included in this scope are epidemiology, behavioral science, and health services research.